Skip to main content

Labor and Delivery Complication clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial

    Sorry, not yet accepting patients

    This is a phase-III multi-center double-blind randomized controlled trial of 8,000 individuals undergoing a scheduled or prelabor cesarean delivery who are randomized to either adjunctive azithromycin prophylaxis or to placebo. Both groups also will receive standard of care preoperative antibiotics (excluding azithromycin). The primary endpoint is a maternal infection composite defined as any one of the following up to 6 weeks postpartum: endometritis, wound infection, abscess, septic thrombosis, sepsis, pneumonia, pyelonephritis and breast infection.

    San Francisco, California and other locations

Last updated: